The last decades have seen parallel improvements in chemotherapy‐based and
haematopoietic stem cell transplantation (HSCT) regimens for acute myeloid leukaemia …

NUP98/NSD1 has recently been reported in association with poor outcome in acute myeloid
leukemia (AML). Previous studies also observed a high overlap between NUP98/NSD1 and …

Acute myeloid leukemia with t (6; 9)(p22; q34) is listed as a distinct entity in the 2008 World
Health Organization classification, but little is known about the clinical implications of t (6; 9) …

Although acute myelogenous leukemia (AML) accounts for< 20% of leukemia in children, it
is responsible for over half of all pediatric leukemia deaths. Improvement in event-free …

Acute myeloid leukaemia (AML) with t (6; 9)(p23; q34) is a rare subtype associated with
FLT3‐internal tandem duplication (ITD) and poor outcomes. The clinical outcomes of …

Nucleophosmin 1 (NPM1) mutations have been identified in a substantial number of patients
with acute myeloid leukemia (AML). Favorable outcomes in AML cases with NPM1 …

Chromosome gain is frequent in acute myeloid leukemia (AML) and is counted alongside
structural abnormalities when determining karyotype complexity. However, there are few …

The outcomes of children with relapsed acute myeloid leukemia (AML) are known to be
poor, but remain obscure. We retrospectively analyzed 71 patients who had relapsed …

Background We sought to better define the role of hematopoietic cell transplantation (HCT)
in first remission (CR1) for high‐risk pediatric acute myeloid leukemia (AML). Procedures …

We report the first large series (n= 596) of pediatric acute myeloid leukemia (AML) focusing
on modal numbers (MN) from the population‐based NOPHO‐AML trials. Abnormal …